全球子宮內壓力導管市場 -2023-2030
市場調查報告書
商品編碼
1374783

全球子宮內壓力導管市場 -2023-2030

Global Intrauterine Pressure Catheters Market -2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

多年來,全球子宮內壓力導管市場經歷了顯著的成長和轉變,影響其動態的因素有很多。分娩時將測量子宮收縮力的子宮內壓力導管 (IUPC) 放入羊膜囊中。

子宮內壓力導管利用導管尖端的壓力感測器直接測量羊膜腔的壓力,從而定量測量宮縮力。收縮率以毫米汞柱為單位進行測量,並在連接相關電纜後以圖形方式顯示在監視器上。

政府新產品的推出和研究,特別是在發展中經濟體,將繼續推動先進的液體填充導管或換能器尖端導管的使用,並推動全球子宮內壓力導管市場。各自的創新產品可用於不同年齡層的人。

市場動態:促進因素與限制因素

不斷加強合作和擴張

在高投資、收入水準和基礎設施發展的推動下,已開發經濟體的醫療保健產業不斷改善。由於懷孕率上升,一些國家對子宮內壓力導管的需求量很大。不同國家之間技術進步的各種合作、收購和產品發布將是推動市場成長的關鍵因素。

皮爾蘭市和皮爾蘭經濟發展公司 (PEDC) 的領導層表示,2021 年 12 月 17 日,皮爾蘭下柯比區已被宣佈為 Millar, Inc. 的新總部。為了將突破性的技術進步轉化為拯救生命的醫療發明,Millar, Inc. 作為壓力感測器產品的知名開發商和生產商,與世界製造、醫療保健和技術領域的權威機構合作。

此外,2022 年 1 月 10 日,Nuvo 推出的經 FDA 批准的遠端妊娠監測平台 INVU 由 Nuvo 處方啟動,由私人公司 Nuvo Group 進行行銷。 Nuvo Group 與 Unified Women's Healthcare 合作,這是該國最大、最多元化的醫生執業管理公司,專門為女性提供服務。

此外,擴大利用新技術和不同類型的子宮內壓力導管進行管理。妊娠風險的上升和創新管理產品開發研究的增加將是推動子宮內壓力導管市場成長的主要因素。

與子宮內壓力導管相關的併發症

子宮內壓力導管插入是產房和分娩室經常進行的常見技術,相關問題很少。大量研究已將子宮內壓力導管的應用及其罕見的負面影響與孕產婦和新生兒發病率聯繫起來。

與植入子宮內壓力導管相關的一個不常見的報告後果是子宮穿孔。應小心插入子宮內壓力導管,了解任何潛在後果將有助於早期診斷和選擇最佳治療方案。

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按產品類型分類
  • 最終使用者的片段
  • 按地區分類

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 不斷加強合作和擴張
      • 不斷進步的技術進步與發展
    • 限制
      • 與子宮內壓力導管相關的併發症
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • SWOT分析
  • 專利分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按產品類型

  • 充液導管
  • 探頭導管

第 8 章:最終用戶

  • 醫院
  • 門診手術中心
  • 老年科

第 9 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章:公司簡介

  • Cardinal Health
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Koninklijke Philips NV
  • Utah Medical Products, Inc.
  • CooperSurgical Inc.
  • Laborie
  • GE HealthCare
  • Cook
  • VYAIRE
  • Millar, Inc.
  • Clinical Innovations, LLC.

第 12 章:附錄

簡介目錄
Product Code: MD7190

Overview

The global intrauterine pressure catheters market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. An intrauterine pressure catheter (IUPC), which measures the force of uterine contractions, is put into the amniotic sac during labor.

Utilizing a pressure transducer at the catheter's tip, intrauterine pressure catheters measure the amniotic space's pressure directly, providing a quantitative measurement of the contraction's force. Contraction is measured in mm Hg and graphically shown on the monitor following connection to the relevant cable.

Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fluid-filled catheters or Transducer-tipped Catheters and boost the global intrauterine pressure catheters market. The respective innovative products are may be utilized in people with different age groups.

Market Dynamics: Drivers & Restraints

Growing collaborations and expansion

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for intrauterine pressure catheters owing to the rising pregnancies. Various collaborations, acquisitions and product launches with technological advancements among different countries will be a crucial factor driving the growth of the market.

On December 17, 2021, the Lower Kirby District of Pearland has been announced as the new headquarters for Millar, Inc., according to the leadership of the City of Pearland along with the Pearland Economic Development Corporation (PEDC). In order to transform ground-breaking technological advancements into life-saving medical inventions, Millar, Inc., an established developer and producer of pressure sensor-enabled products, collaborates with world authorities in manufacturing, healthcare, and technology.

Additionally on January 10, 2022, the FDA-cleared, remote pregnancy monitoring platform INVU which is prescription-initiated, by Nuvo is being marketed by Nuvo Group, a private company. Nuvo Group partnered with Unified Women's Healthcare, the largest, most diverse physician practice management company in the country that caters exclusively to women.

Furthermore, the rising utilization of novel technology and different types of intrauterine pressure catheters for the management purposes. Rising risks in pregnancies and increasing research for innovative management product development will be a major factor driving the growth of the intrauterine pressure catheters market.

Complications associated with intrauterine pressure catheters

Intrauterine pressure catheter insertion is a common technique carried regularly in labor and delivery units with minimal related problems. Numerous investigations have linked the application of intrauterine pressure catheters and its uncommon negative effects to maternal and newborn morbidity.

A uncommon reported consequence linked to the implantation of intrauterine pressure catheters is uterine perforation. Intrauterine pressure catheters should be inserted with care, and being aware of any potential consequences will help with an early diagnosis and the selection of the best course of action.

Segment Analysis

The global intrauterine pressure catheters market is segmented based on product type, end user and region.

Transducer-tipped Catheter segment accounted for approximately 73% of market share

A catheter tip pressure transducer is utilized for sensing the pressure in various sections of a living organism correctly and securely which comprises a pressure sensor positioned within the tip portion of a catheter. A pressure-sensitive diaphragm on which strain gauges are produced using the diffusion process is part of the pressure sensor.

The pressure sensor is attached but not firmly fastened to an insulated supporting element. Without being impacted by the thermal stresses that occur in the supporting element, the pressure sensor properly measures pressure. The uterine cavity is the intended location for this device. Many of the drawbacks of the conventional approach are eliminated with such a system.

According to the Journal of Reproductive Medicine publication, 2021, as safe as or safer than IUPCs already in use, Koala is just as functionally effective as or more so than IUPCs. The Koala also showed a number of benefits, such as a softer, shorter catheter tip that makes it easier to insert, a simpler, more compact design that makes it safer to insert and easier to operate, and precise transmission of signals to monitor.

Geographical Penetration

North America accounted for around 38% of market share in 2022

Due to the rising need for intrauterine pressure catheters in healthcare, manufacturers in North America have chances of increasing their operations. Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or medical device business establishment across the region are also contributing to the growth of intrauterine pressure catheters market share of this region.

The market in this area is growing as people become more aware of various novel innovative products such as fluid-filled catheters. The aforementioned elements attest to North America's hegemonic position in the world. An intrauterine pressure catheter is used to monitor 15-20% (600,000-800,000) of the 4 million deliveries that take place each year in the United States. This method gives the practitioner diagnostic data that is helpful for determining the pressures produced by the myometrium and monitoring the health of the fetus throughout labor and delivery.

North America continues to be a key player in the global intrauterine pressure catheters market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for intrauterine pressure catheters in the U.S. United States have been proactive in executing several initiatives or researches, stimulating intrauterine pressure catheters demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global intrauterine pressure catheters market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all over the world were disturbed by the pandemic's broad lockdowns and strict limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for intrauterine pressure catheters. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global intrauterine pressure catheters market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like transducer-tipped catheter.

Key Developments

  • On March 22, 2023, in order to create a more inclusive pregnancy care encounter from the prenatal stage through delivery and labor, Royal Philips, an international pioneer in health technological devices, and Nuvo Group, a privately held corporation marketing INVU by Nuvo, a prescription-initiated, FDA-cleared, remote pregnancy tracking platform, have joined forces. Philips and Nuvo will work together to facilitate remote fetal monitoring pilot initiatives that increase access to and adherence to recommended care in outlying locations. The first program will be in a rural Colorado community.
  • On August 16, 2022, the Australian Therapeutic Goods Administration (TGA) has given the Mikro-Cath Pressure Catheter manufacturer Millar, Inc. clearance to market it. The Mikro-Cath is a single-use pressure catheter designed for use in diagnostic and research procedures in medicine. For monitoring intra-compartmental, cardiovascular pressures and airway in people, the catheter is advised. The catheter is utilized as a short-term, restricted body contact minimally invasive device.

Competitive Landscape

The major global players in the market include: Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Laborie, GE HealthCare, Cook, VYAIRE, Millar, Inc. and Clinical Innovations, LLC among others.

Why Purchase the Report?

  • To visualize the global intrauterine pressure catheters market segmentation based on product type, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of intrauterine pressure catheters market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global intrauterine pressure catheters market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by End User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing collaborations and expansion
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. Complications associated with intrauterine pressure catheters
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. SWOT Analysis
  • 5.6. Patent Analysis
  • 5.7. Russia-Ukraine War Impact Analysis
  • 5.8. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Fluid-filled Catheters*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Transducer-tipped Catheter

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Geriatric

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Cardinal Health*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Koninklijke Philips N.V.
  • 11.3. Utah Medical Products, Inc.
  • 11.4. CooperSurgical Inc.
  • 11.5. Laborie
  • 11.6. GE HealthCare
  • 11.7. Cook
  • 11.8. VYAIRE
  • 11.9. Millar, Inc.
  • 11.10. Clinical Innovations, LLC.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us